BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9

• Press Releases

  SU2C DREAM TEAM TARGETS EARLY DETECTION OF GASTRIC CANCER

  January 9, 2026

   · 

  7 min read
• Press Releases

  DELFI Diagnostics Appoints Cindy Soriano as Chief Financial Officer and Announces Participation in 44th Annual J.P. Morgan Healthcare Conference

  January 9, 2026

   · 

  2 min read
• Press Releases

  One Genomics and CiRA Foundation Announce Strategic Research Collaboration to Advance Precision Genome Engineering

  January 9, 2026

   · 

  2 min read
• Press Releases

  ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

  January 9, 2026

   · 

  1 min read
• Press Releases

  Wellvana Appoints Jim Murray as President and Chief Financial Officer

  January 9, 2026

   · 

  2 min read
• Press Releases

  ALK to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco

  January 9, 2026

   · 

  1 min read
• Press Releases

  Oncolytics Biotech® Provides Update on Intellectual Property Strategy and Patent Filings

  January 9, 2026

   · 

  4 min read
• Press Releases

  A2 Biotherapeutics Announces FDA Clearance of IND for A2B543 for Treatment of Adults with Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors that Express Mesothelin and Have Lost HLA-A*02 Expression

  January 9, 2026

   · 

  5 min read
• Press Releases

  MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease

  January 9, 2026

   · 

  7 min read
• Press Releases

  ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY PLATFORM

  January 9, 2026

   · 

  3 min read